NEW YORK (GenomeWeb News) - Link Technologies has entered a non-exclusive license agreement with PNA Inventor Group that will allow it to manufacture and sell monomers for peptide nucleic acid synthesis worldwide.
 
Link Technologies said that numerous uses for PNAs have been identified or proposed for molecular biology applications, diagnostic assays, and antisense therapies.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

University of California, San Diego, researchers have developed a gene drive to control a fruit-destroying fly.

A new study of a β-thalassemia gene therapy appears promising, according to NPR.

Futurism writes that gene doping could be the next generation of cheating in sports.

In Nature this week: hair color genes, hybridization between 13-year and 17-year cicadas, and more.